Cover Image
Read Now

Stem cell therapies opportunities for ensuring the quality and safety of clinical offerings : summary of a joint workshop by the Institute of Medicine, the National Academy of Sciences, and the International Society for Stem Cell Research

Bibliographic Details
Main Author: Berger, Adam C.
Corporate Authors: Institute of Medicine (U.S.) Board on Health Sciences Policy, National Research Council (U.S.) Board on Life Sciences, International Society for Stem Cell Research, Stem Cell Therapies: Opportunities for Ensuring the Quality and Safety of Unregulated Clinical Offerings (Workshop) (2013, Washington, D.C.)
Other Authors: Beachy, Sarah H. ([rapporteur]), Olson, Steve ([rapporteur])
Format: eBook
Language:English
Published: Washington, D.C. National Academies Press [2014]©2014, 2014
Subjects:
Legislation, Medical
Stem Cells
Patient Education As Topic
Patient Safety / Standards
Stem Cell Transplantation / Legislation & Jurisprudence
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 02364nam a2200421 u 4500
001 EB000944713
003 EBX01000000000000000738303
005 00000000000000.0
007 tu|||||||||||||||||||||
008 150223 r ||| eng
020 |a 0309303001 
020 |a 9780309303002 
050 4 |a QH588.S83 
100 1 |a Berger, Adam C. 
245 0 0 |a Stem cell therapies  |h Elektronische Ressource  |b opportunities for ensuring the quality and safety of clinical offerings : summary of a joint workshop by the Institute of Medicine, the National Academy of Sciences, and the International Society for Stem Cell Research  |c Adam C. Berger, Sarah H. Beachy, and Steve Olson, rapporteurs ; Board on Health Sciences Policy, Institute of Medicine ; Board on Life Sciences, Division on Earth and Life Studies, Institute of Medicine and National Research Council of the National Academies 
260 |a Washington, D.C.  |b National Academies Press  |c [2014]©2014, 2014 
300 |a xx, 87 pages  |b 2 color illustrations  |c 23 cm 
505 0 |a Introduction and themes of the workshop -- Stem cell therapies : knowns and unknowns -- Patients' experiences -- Comparative regulatory and legal frameworks -- The roles of professional societies -- Moving forward 
505 0 |a Includes bibliographical references (pages 55-59) 
653 |a Legislation, Medical 
653 |a Stem Cells 
653 |a Patient Education as Topic 
653 |a Patient Safety / standards 
653 |a Stem Cell Transplantation / legislation & jurisprudence 
700 1 |a Beachy, Sarah H.  |e [rapporteur] 
700 1 |a Olson, Steve  |e [rapporteur] 
710 2 |a Institute of Medicine (U.S.)  |b Board on Health Sciences Policy 
710 2 |a National Research Council (U.S.)  |b Board on Life Sciences 
710 2 |a International Society for Stem Cell Research 
710 2 |a Stem Cell Therapies: Opportunities for Ensuring the Quality and Safety of Unregulated Clinical Offerings (Workshop) (2013, Washington, D.C.) 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK223197  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
856 4 0 |u http://www.nap.edu/catalog.php?record_id=18746  |3 Volltext  |n Provider site  |3 Volltext 
082 0 |a 580 
082 0 |a 370 
082 0 |a 340 
082 0 |a 616.02/774 

Similar Items